002019 亿帆医药
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)1.751-6.4502.2053.28012.151
总资产报酬率 ROA (%)1.255-4.5841.5482.3398.531
投入资产回报率 ROIC (%)1.385-5.0541.7072.5919.643

边际利润分析
销售毛利率 (%)47.36647.84048.63541.46946.477
营业利润率 (%)11.980-21.6983.7484.81320.083
息税前利润/营业总收入 (%)13.292-19.9164.6656.41921.258
净利润/营业总收入 (%)8.865-21.7713.3125.49417.247

收益指标分析
经营活动净收益/利润总额(%)85.904-3.012118.914106.87889.171
价值变动净收益/利润总额(%)-2.8701.733-11.250-2.1300.642
营业外收支净额/利润总额(%)0.038-1.5748.249-0.668-0.356

偿债能力分析
流动比率 (X)1.4281.4861.6781.5581.647
速动比率 (X)1.0301.0621.3001.2691.373
资产负债率 (%)29.13128.21627.08327.8710.250
带息债务/全部投入资本 (%)18.65418.59319.21419.67315.838
股东权益/带息债务 (%)424.089425.239404.494391.875511.385
股东权益/负债合计 (%)244.977255.052259.376251.733290.328
利息保障倍数 (X)10.170-13.7728.0483.91917.052

营运能力分析
应收账款周转天数 (天)81.275101.414105.96885.02265.015
存货周转天数 (天)123.447149.262136.53687.02873.610